Guidelines : Axial Spondyloarthritis
Detail
Condition :
Axial Spondyloarthritis
Keywords :
ankylosing spondylitis, AS, non-radiographic axial spondyloarthritis, nrSpA, adalimumab, etanercept, golimumab, infliximab, certolizumab, secukinumab, ixekizumab, upadacitinib, tofacitinib, bimekizumab, Biologic, anti-TNF, TNF-alpha, monoclonal antibody, cytokine modulator, axial spondyloarthritis, AS, IL17A, interleukin, JAK inhibitor, Janus Kinase, Jakinib
BNF Codes :
Committee Recommendations
Date
Committee Name
Narrative
Traffic Light Status
05 February 2025
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) approves the updated spondyloarthritis treatment pathway.
See narrative
Documents
Type
Document
Review Date
Supplementary documents (CCG specific documents)
No records returned.
Drugs
Below are listed drugs that are used to treat Axial Spondyloarthritis.
- Adalimumab Red
- Bimekizumab See narrative
- Certolizumab Red
- Etanercept Red
- Golimumab Red
- Infliximab Red
- Ixekizumab Red
- Secukinumab See narrative
- Tofacitinib See narrative
- Upadacitinib Red